FULVESTRANT
NDC 70700-284, fulvestrant, injection, solution, from Xiromed, LLC.
- Product NDC
- 70700-284
- Status
- Listed
- Labeler
- Xiromed, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213553
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70700-284 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FULVESTRANT50 mg/mL
Pharmacologic classes
Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70700-284-98 | 70700028498 | 2 SYRINGE, GLASS in 1 CARTON (70700-284-98) / 5 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/840cd7c0-9f33-f74e-f136-de7fe899bfb4Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=70700-284
Use it
Look up 70700-284 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70700-284 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70700-284. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.